Top

Published in:

Open Access 01-08-2018 | Journal club

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease

Authors: M. D. Willis, N. P. Robertson

Published in: Journal of Neurology | Issue 8/2018

Excerpt

Rather than being homogenous, it is becoming increasingly clear that central nervous system (CNS) neuroinflammatory diseases have a broad range of immunological aetiologies. In particular, the discovery of novel CNS antibodies has helped define new clinical disease entities. A greater understanding of the clinical phenomenology associated with these disorders will now be important to aid diagnosis and guide appropriate management. …

Title: Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
Authors: M. D. Willis
N. P. Robertson
Publication date: 01-08-2018
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 8/2018
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-018-8963-z

At a glance: The STEP trials

Springer Medicine

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2018

Application value of serum biomarkers for choosing memantine therapy for moderate AD

Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study

Comparison of CT black hole sign and other CT features in predicting hematoma expansion in patients with ICH

Detection of JC virus archetype in cerebrospinal fluid in a MS patient with dimethylfumarate treatment without lymphopenia or signs of PML

Primary lateral sclerosis and the amyotrophic lateral sclerosis–frontotemporal dementia spectrum

Kazimierz Orzechowski (1878–1942)